Fri, 19 Oct 2018 14:28:28: AbbVie CFO Chase spearheaded its Abbott spinoff and Imbruvica buy—and now he's retiring

Fri, 19 Oct 2018 14:14:11: NICE spurns Lilly’s breast cancer drug Verzenio in favor of rivals from Pfizer and Novartis

Fri, 19 Oct 2018 14:06:22: Panel backing for key Shire drug beefs up Takeda's case for its $62B buyout

Fri, 19 Oct 2018 13:15:41: After Philippines safety scandal, Sanofi's Dengvaxia set for European approval

Fri, 19 Oct 2018 08:28:03: FiercePharmaAsia—China’s $1.3B vaccine fine; Lantus biosim retreat; Taiho’s VC fund

Fri, 19 Oct 2018 07:13:21: ESMO 2018 spotlights Merck’s Keytruda, Pfizer's Ibrance, AstraZeneca’s Lynparza and more

Thu, 18 Oct 2018 22:28:31: Clovis bolsters Rubraca's PARP-leading prostate cancer bid with big-time response data

Thu, 18 Oct 2018 15:29:35: Merck's Keytruda, ready to challenge Bristol-Myers Squibb, posts kidney cancer combination win

Thu, 18 Oct 2018 14:57:34: Insys drove ‘explosive' opioid painkiller sales by ‘owning’ physicians, Senate report reveals

Thu, 18 Oct 2018 14:04:46: AbbVie wards off another Humira biosim challenger with Fresenius Kabi settlement

Thu, 18 Oct 2018 13:44:43: GlaxoSmithKline’s job whacking touches U.S. consumer plant

Wed, 17 Oct 2018 19:34:28: Working through CEO swap, Pfizer plots job cuts in drive for 'simpler' structure

Wed, 17 Oct 2018 15:05:59: U.K. fights EpiPen shortage by extending injector expiry dates

Wed, 17 Oct 2018 14:58:22: Minnesota AG targets Sanofi, Eli Lilly and Novo Nordisk in latest insulin pricing attack

Wed, 17 Oct 2018 13:53:40: Can Pfizer's new breast cancer drug Talzenna really make a dent in the PARP field?

Wed, 17 Oct 2018 13:38:08: Mannkind's Afrezza Facebook page gets slapped by FDA's promo police

Wed, 17 Oct 2018 13:27:10: FDA spanks South Korea's Hanlim Pharm with warning letter

Wed, 17 Oct 2018 13:13:53: Amgen, Lilly migraine drugs nab Express Scripts backing, but Teva's shut out

Tue, 16 Oct 2018 20:18:10: FCB Health launches next-generation big data agency to better tell pharma brand stories

Tue, 16 Oct 2018 18:35:15: Officials deny shortage of Seqirus' Fluad in the U.K. as season nears

Tue, 16 Oct 2018 15:15:44: Azar deals woe to DTC—and a slap to Big Pharma—with vow to force prices into drug ads

Tue, 16 Oct 2018 14:56:50: Johnson & Johnson would be just fine without Zytiga, executives insist as patent decision looms

Tue, 16 Oct 2018 14:41:05: EU expands look at Zhejiang Huahai as impurities show up in other 'sartans'

Tue, 16 Oct 2018 13:38:35: Sanofi, Regeneron score positive Dupixent data in sinusitis as they await key FDA asthma verdict

Mon, 15 Oct 2018 19:11:17: Flu shot giant Sanofi teams with American Lung Association on get-vaccinated message to U.S. seniors